Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease - ScienceDirect
NAFLD Fibrosis Score Calculator
Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome | Article
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice
NFS at Fatty Liver Foundation
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings
PDPM Payment Calculator – FY2021 PPS PDPM Rates (Urban) - Montero Therapy and MDS Services
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library
Non-Alcoholic Fatty Liver Disease
2nd screening system for NAFLD with hepatic fibrosis and HCC screening:... | Download Scientific Diagram
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
Non-invasive tests of non-alcoholic fatty liver disease | Chinese Medical Journal
Frontiers | Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Non Alcoholic Fatty Liver Disease NAFLD - ppt download
NAFLD Fibrosis Score Calculator
The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study - ScienceDirect
Life | Free Full-Text | Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease | PLOS ONE
NPS Calculator: Calculate your Net Promoter Score
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study - The Lancet Gastroenterology & Hepatology
